Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscription Services
Promote Your Event
Submission Forms
Place an Ad
Weather
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Items For Sale
Jobs
Pets
Auctions, Estate & Garage Sales
Place an ad
Services
Community
Personals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Catalyst Pharm Inc
(NQ:
CPRX
)
15.49
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 31, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
47
Open
15.49
Bid (Size)
15.48 (1)
Ask (Size)
15.80 (33)
Prev. Close
15.49
Today's Range
15.49 - 15.49
52wk Range
5.580 - 22.11
Shares Outstanding
102,780,151
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
Top News
More News
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
January 27, 2023
Stocks reacted well to uneven earnings and economic reports.
Via
Investor's Business Daily
Down 30% in a Day, Is Catalyst Pharmaceuticals Doomed?
January 26, 2023
Things aren't as bad as they might seem.
Via
The Motley Fool
Performance
YTD
-14.23%
-14.23%
1 Month
-14.23%
-14.23%
3 Month
+10.80%
+10.80%
6 Month
+46.41%
+46.41%
1 Year
+166.15%
+166.15%
More News
Read More
Here's How Much $1000 Invested In Catalyst Pharmaceuticals 15 Years Ago Would Be Worth Today
January 25, 2023
Via
Benzinga
How Former IBD 50 Leader Catalyst Pharma Is Trying To Claw Back From A 29% Setback
January 25, 2023
Via
Investor's Business Daily
$1000 Invested In This Stock 10 Years Ago Would Be Worth $27,000 Today
January 23, 2023
Via
Benzinga
Analyst Expectations for Catalyst Pharmaceuticals's Future
January 19, 2023
Via
Benzinga
HC Wainwright & Co. Maintains Buy Rating for Catalyst Pharmaceuticals: Here's What You Need To Know
December 21, 2022
Via
Benzinga
Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
January 25, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
Globe NewsWire
Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
January 25, 2023
Via
MarketBeat
Nasdaq Rises 1.5%; Pliant Therapeutics Shares Spike Higher
January 23, 2023
Via
Benzinga
Catalyst Pharmaceuticals Comments on FDA's Announcement of its Position on Orphan Drug Exclusivity In Light of the 11th Circuit Decision in Catalyst Pharmaceuticals, Inc. v. Becerra
January 23, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
Globe NewsWire
Why Evoqua Water Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 23, 2023
Via
Benzinga
Dow, Nasdaq Boasting Triple-Digit Midday Lead
January 23, 2023
Via
Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
January 23, 2023
Via
Benzinga
Dow Jumps Over 300 Points; Crude Oil Up 1%
January 23, 2023
Via
Benzinga
Catalyst Pharmaceuticals, Xylem And Other Big Stocks Moving Lower On Monday
January 23, 2023
Via
Benzinga
Catalyst Pharma Shares Take A Hit As Teva Files For Generic Version Of Its Lead Product
January 23, 2023
Via
Benzinga
US Stocks Mostly Higher; Synchrony Financial Earnings Top Views
January 23, 2023
Via
Benzinga
No. 1 IBD 50 Stock Catalyst Tanks As Teva Looks To Knock Off Its Only Product
January 23, 2023
Via
Investor's Business Daily
Why Catalyst Pharmaceuticals Shares Are Moving
January 23, 2023
Via
Benzinga
Catalyst Pharmaceuticals Notified of Abbreviated New Drug Application Filing for FIRDAPSE®
January 23, 2023
From
Catalyst Pharmaceuticals, Inc.
Via
Globe NewsWire
2 Biotechs Making Waves With A Single Product in their Pipeline
January 11, 2023
Via
MarketBeat
IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
January 09, 2023
Via
Investor's Business Daily
Top Picks For 2023: Catalyst Pharmaceuticals - Sunday, Jan. 8
January 08, 2023
Via
Talk Markets
Top Picks For 2023: Catalyst Pharmaceuticals
January 02, 2023
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.